Several potential jurors at the federal securities fraud trial of Martin ‘Pharma Bro’ Shkreli were excused on Monday after telling the judge they couldn’t be impartial toward the flamboyant former pharmaceutical CEO because of his notoriety for raising the cost of a life-saving drug 5,000 percent. Though Shkreli’s notoriety came from Daraprim, a drug used to treat toxoplasmosis and HIV, the federal securities fraud case is unrelated.
Get the cheapest hosting in the world for only one dollar and experience unlimited features of our hosting services. If you have any doubt, feel free to try our free hosting service.
You must log in to post a comment.